Human Biome S.A.
PrivateLast Round
Series A
Mar 1, 2026
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Human Biome S.A. is a biotechnology company that develops New-Generation Biotherapeutics (NGB) and Fecal Microbiota Transplantation (FMT) preparations to treat chronic diseases and combat antimicrobial resistance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Human Biome S.A. Comparables
Compare Human Biome S.A. with similar companies based on industry and business-model similarity.
Human Biome S.A. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 1, 2026 |
Human Biome S.A. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| COBIN Angels | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 20, 2026
Monthly visitors increased 56% MoM.
- Apr 10, 2026
Grew 17% QoQ, from 24 to 28 employees.
Human Biome S.A. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Human Biome S.A.'s valuation, stock price, and market status.